clinical / clinicalBone Marrow Transplant

Andrew Grigg

安德鲁·格里格

MBBS, MD, FRACP, FRCPA

🏢Royal Melbourne Hospital / University of Melbourne(墨尔本皇家医院/墨尔本大学)🌐Australia

Head, Clinical Haematology; Professor of Medicine临床血液科主任；医学教授

h-index

Key Papers

Awards

Key Contributions

👥Biography 个人简介

Andrew Grigg is Australia's most influential bone marrow transplant clinician and researcher, leading the Royal Melbourne Hospital program and contributing pivotal Australasian transplant outcomes data while advancing care for AML, MDS, and lymphoma through transplantation.

🧪Research Fields 研究领域

Allogeneic HSCT异基因造血干细胞移植

Hematologic Malignancies血液系统恶性肿瘤

Transplant Outcomes移植结局

AML and MDS TransplantAML和MDS移植

Infection after Transplant移植后感染

🎓Key Contributions 主要贡献

Australian Transplant Outcomes Research

Led landmark Australasian Leukaemia and Lymphoma Group studies defining transplant outcomes in AML, MDS, and lymphoma in the Asia-Pacific context, informing regional and international practice guidelines.

Post-Transplant Infectious Complications

Advanced understanding and management of post-transplant infectious complications including CMV, invasive fungal disease, and bacterial infections, developing risk-stratified surveillance protocols adopted across Australian transplant centers.

Representative Works 代表性著作

[1]

Allogeneic haematopoietic stem cell transplantation for AML in first complete remission: a retrospective Australasian analysis

Internal Medicine Journal (2020)

National outcomes analysis defining survival, relapse, and transplant-related mortality benchmarks for Australian AML transplant patients.

[2]

Outcomes of allogeneic HSCT for myelodysplastic syndrome: an Australasian Leukaemia and Lymphoma Group study

Leukemia Research (2022)

Multi-center retrospective defining impact of MDS subtype, conditioning intensity, and donor type on transplant outcomes.

🏆Awards & Recognition 奖项与荣誉

🏆Royal Australasian College of Physicians Fellowship Award

🏆Leukaemia Foundation of Australia Distinguished Research Award

🏆ALLG Lifetime Contribution Award

📄Data Sources 数据来源

Institution

Last updated: 2026-01-15 | All information from publicly available academic sources

Related Experts 相关专家

Hope S. Rugo

University of California, San Francisco (UCSF)

Antibody-Drug Conjugates in Metastatic Breast CancerASCENT Trial and Sacituzumab Govitecan

Maryam B. Lustberg

Yale School of Medicine / Yale Cancer Center

Cardiotoxicity of CDK4/6 Inhibitors and Endocrine TherapyCancer Treatment-Related Cardiovascular Disease

Sara M. Tolaney

Dana-Farber Cancer Institute / Harvard Medical School

T-DM1 and KATHERINE Trial in Residual Disease After Neoadjuvant TherapyTrastuzumab Deruxtecan (T-DXd) and DESTINY-Breast Trials

Carlos H. Barrios

PUCRS (Pontifical Catholic University of Rio Grande do Sul) / Hospital São Lucas, Porto Alegre, Brazil

CDK4/6 Inhibitors in Low- and Middle-Income Countries (LMIC)Global Breast Cancer Clinical Trials and Access

关注安德鲁·格里格的研究动态

Follow Andrew Grigg's research updates

留下邮箱，当我们发布与 Andrew Grigg（Royal Melbourne Hospital / University of Melbourne）相关的新研究或访谈时，我们会通知你。

Explore More Experts

Discover the researchers shaping the future of cancer treatment

Browse All Experts Read Research Insights

International Translational Oncology Exchange